Skip to content

13F-HR filed by BAUPOST GROUP LLC/MA

BAUPOST GROUP LLC/MA filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-13, with 41 holding rows worth $6,002,477,000.

Accession
0001140361-15-041178
Filed
2015-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2015

A holdings report, 41 entries on the cover page, a total value of $6,002,477,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,002,477,000 with VALUE read as thousands by filing date, 13F file number 028-07120. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHENIERE ENERGY INC COM NEW16411R208Stock22,669,730$1,094,948,000thousands by filing date
VIASAT INC92552V100COM11,533,137$741,465,000thousands by filing date
ALCOA INC013817101COM52,270,000$504,928,000thousands by filing date
PIONEER NATURAL RESOURCES CO723787107COM4,137,000$503,225,000thousands by filing date
ANTERO RESOURCES CORP COM03674X106Stock16,099,763$340,671,000thousands by filing date
PAYPALHLDGSINC70450Y103STOK10,904,852$338,487,000thousands by filing date
PBF ENERGY INC69318G106CL A11,025,000$311,236,000thousands by filing date
EBAY INC. COM278642103Stock9,315,000$227,659,000thousands by filing date
FOX CORP CLASS B90130A200COM6,527,500$176,699,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock5,359,632$168,507,000thousands by filing date
THERAVANCE INC88338T104COMMON STOCK19,815,983$142,279,000thousands by filing date
FORWARD PHARMA A/S34986J105SPONSORED ADR5,367,300$126,454,000thousands by filing date
OLIN CORP680665205COM PAR $17,000,000$117,670,000thousands by filing date
TWENTY FIRST CENTY FOX INC90130A101CL A4,097,500$110,551,000thousands by filing date
VERITIV CORP923454102COM2,795,693$104,112,000thousands by filing date
AERCAP HOLDINGS NV SHSN00985106Stock2,450,000$93,688,000thousands by filing date
SUNEDISON SEMIY8213L102Common Stock8,372,979$88,251,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK25,791,678$84,522,000thousands by filing date
NOVAGOLD RESOURCES INC66987E206COM NEW21,688,300$78,295,000thousands by filing date
THERAVANCE BIOPHARMA INCG8807B106COM6,420,028$70,556,000thousands by filing date
FRONTIER COMMUNICATIONS CORP35906A108COM13,500,000$64,125,000thousands by filing date
CHIPMOS TECH BERMUDA LTDG2110R114SHS3,751,853$61,605,000thousands by filing date
KLX INC482539103COM1,500,000$53,610,000thousands by filing date
CITIGROUP INC172967226WARRANT102,553,207$47,174,000thousands by filing date
LIFELOCK INC COM53224V100COM4,460,760$39,076,000thousands by filing date
BELLATRIX EXPLORATION LTD078314101COM23,990,500$36,466,000thousands by filing date
OCWEN FINL CORP675746309COM NEW5,200,427$34,895,000thousands by filing date
KOSMOS ENERGY LTDG5315B107SHS6,000,000$33,480,000thousands by filing date
THERAVANCE INC88338TAB0CORPORATE OBLIG48,230,000$31,591,000thousands by filing dateprincipal
FRONTIER COMMUNICATIONS CORP35906A207PFD CONV SER-A325,000$30,274,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity1,544,498$29,345,000thousands by filing date
AMERICAN INTL GROUP INC026874156*W EXP 01/19/2021,258,496$28,568,000thousands by filing date
BIOTIE THERAPIES OYJ09074D103SPONSORED ADR1,256,006$16,441,000thousands by filing date
KINDRED BIOSCIENCES INC COM494577109Stock3,013,848$15,672,000thousands by filing date
Micron Technology,Inc.595112103COM1,000,000$14,980,000thousands by filing date
SUNRUN INC86771W105COM1,170,910$12,142,000thousands by filing date
ALLIANCE ONE INTL INC018772301COM NEW458,364$9,341,000thousands by filing date
ALON USA PARTNERS LP UNIT LTD PARTNERSHIP INT02052T109COM363,188$8,466,000thousands by filing date
SANCHEZ ENERGY CORP79970Y105COMMON STOCK1,000,000$6,150,000thousands by filing date
NOVACOPPER INC66988K102COM10,600,758$3,344,000thousands by filing date
OREXIGEN THERAPEUTICS INC686164104COMMON STOCK821,363$1,529,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-15-041178this filing2015-11-13acceptance time not in the bulk data set